Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration

Endoplasmic reticulum stress (ERS) is a kind of cell response for coping with hypoxia and other stresses. Pieces of evidence show that continuous stress can promote the occurrence, development, and drug resistance of tumors through the unfolded protein response. Therefore, the abnormal ac-tivation of ERS and its downstream signaling pathways not only can regulate tumor growth and metastasis but also profoundly affect the efficacy of antitumor therapy. Therefore, revealing the molecular mechanism of ERS may be expected to solve the problem of tumor multidrug resistance (MDR) and become a novel strategy for the treatment of refractory and recurrent tumors. This re-view summarized the mechanism of ERS and tumor MDR, reviewed the relationship between ERS and tumor MDR, introduced the research status of tumor tissue and ERS, and previewed the prospect of targeting ERS to improve the therapeutic effect of tumor MDR. This article aims to provide researchers and clinicians with new ideas and inspiration for basic antitumor treatment.

[1]  G. Sethi,et al.  (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy , 2023, Medicinal research reviews.

[2]  M. Foti,et al.  Endoplasmic Reticulum Stress in Renal Cell Carcinoma , 2023, International journal of molecular sciences.

[3]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[4]  Yonghui Zhang,et al.  Endoplasmic reticulum stress in melanoma pathogenesis and resistance. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  Xuepeng Wang,et al.  Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy , 2022, Signal Transduction and Targeted Therapy.

[6]  Hui Cao,et al.  Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges , 2022, Frontiers in Pharmacology.

[7]  G. Robertson,et al.  Drug-tolerant persister cells in cancer therapy resistance. , 2022, Cancer research.

[8]  L. Sequist,et al.  Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management , 2022, Nature Reviews Clinical Oncology.

[9]  X. Xiong,et al.  Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cerebral Ischemia/Reperfusion Injury , 2022, Frontiers in Cellular Neuroscience.

[10]  Liying Hao,et al.  YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance , 2022, Cell Death & Disease.

[11]  W.H. Tang,et al.  Icariside II enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells , 2022, International journal of biological sciences.

[12]  Wanqing Chen,et al.  Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.

[13]  F. Heindryckx,et al.  Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma , 2022, Cells.

[14]  Xinghuan Wang,et al.  Glucose-regulated protein 78 modulates cell growth, epithelial–mesenchymal transition, and oxidative stress in the hyperplastic prostate , 2022, Cell death & disease.

[15]  J. Fletcher,et al.  Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition. , 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[16]  Chuanbin Guo,et al.  pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells , 2021, BMC Cancer.

[17]  Longfei Lin,et al.  Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019 , 2021, Journal of Hematology & Oncology.

[18]  D. Ron,et al.  Pharmacological targeting of endoplasmic reticulum stress in disease , 2021, Nature reviews. Drug discovery.

[19]  Chen Liang,et al.  Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives , 2021, Molecular Cancer.

[20]  Feilong Wei,et al.  Sestrin2-Mediated Autophagy Contributes to Drug Resistance via Endoplasmic Reticulum Stress in Human Osteosarcoma , 2021, Frontiers in Cell and Developmental Biology.

[21]  S. Klauck,et al.  Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK/eIF2α/ATF4 pathway. , 2021, Biochemical pharmacology.

[22]  Yinglei Zhai,et al.  Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy , 2021, Acta pharmaceutica Sinica. B.

[23]  Ruihua Xu,et al.  Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 , 2021, Cancer communications.

[24]  M. Ashrafizadeh,et al.  New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Hongmei Zhou,et al.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer , 2021, Signal Transduction and Targeted Therapy.

[26]  Yun Dai,et al.  A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer , 2021, Acta pharmaceutica Sinica. B.

[27]  S. Kang,et al.  Glutathione peroxidase-1 regulates ASK1-dependent apoptosis via interaction with TRAF2 in RIPK3-negative cancer cells , 2021, Experimental & Molecular Medicine.

[28]  Hui Cao,et al.  Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link , 2021, Frontiers in Cell and Developmental Biology.

[29]  Yongheng Chen,et al.  Nanomaterials for cancer therapy: current progress and perspectives , 2021, Journal of Hematology & Oncology.

[30]  Pei-Ming Yang,et al.  PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells , 2021, International journal of molecular sciences.

[31]  A. Mackiewicz,et al.  Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance , 2021, Frontiers in Immunology.

[32]  Xiangxuan Zhao,et al.  Targeting Bcl-2 for cancer therapy. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[33]  M. Schröder,et al.  The Unfolded Protein Response: An Overview , 2021, Biology.

[34]  Yong Li,et al.  Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis , 2021, Redox biology.

[35]  R. Huo,et al.  Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers , 2021, Frontiers in Pharmacology.

[36]  Haiyuan Zhang,et al.  The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance , 2021, Frontiers in Molecular Biosciences.

[37]  M. Ashrafizadeh,et al.  Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance , 2021, Cancers.

[38]  D. Bezerra,et al.  Chloroquine and hydroxychloroquine in antitumor therapies based on related-autophagy mechanisms. , 2021, Pharmacological research.

[39]  Qi Wang,et al.  GRP78 in lung cancer , 2021, Journal of translational medicine.

[40]  Jun Ren,et al.  Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases , 2021, Nature Reviews Cardiology.

[41]  Youhui Wang,et al.  JAK2/STAT3 inhibitor reduced 5-FU resistance and autophagy through ATF6-mediated ER stress , 2021, Journal of receptor and signal transduction research.

[42]  C. Kundu,et al.  5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  C. Croce,et al.  MicroRNA and ER stress in cancer. , 2021, Seminars in cancer biology.

[44]  Xi Chen,et al.  Endoplasmic reticulum stress signals in the tumour and its microenvironment , 2020, Nature Reviews Cancer.

[45]  N. Lou,et al.  Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma , 2020, Aging.

[46]  K. M. Fazili,et al.  The molecular mechanism and functional diversity of UPR signaling sensor IRE1. , 2020, Life sciences.

[47]  Liwei Huang,et al.  Transmissible Endoplasmic Reticulum Stress: A Novel Perspective on Tumor Immunity , 2020, Frontiers in Cell and Developmental Biology.

[48]  A. Lampis,et al.  MicroRNAs as mediators of drug resistance mechanisms. , 2020, Current opinion in pharmacology.

[49]  Maria Nicoletta Moretti,et al.  GADD34 is a modulator of autophagy during starvation , 2020, Science Advances.

[50]  Lei Xu,et al.  Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma , 2020, Acta pharmacologica Sinica.

[51]  E. M. Martín del Valle,et al.  Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine , 2020, Nanomaterials.

[52]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[53]  Yun-Ru Liu,et al.  Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells , 2020, Marine drugs.

[54]  Tianzhi Huang,et al.  Stem cell programs in cancer initiation, progression, and therapy resistance , 2020, Theranostics.

[55]  T. Spicer,et al.  Pharmacologic IRE1/XBP1s Activation Confers Targeted ER Proteostasis Reprogramming , 2020, Nature Chemical Biology.

[56]  C. Hetz,et al.  Mechanisms, regulation and functions of the unfolded protein response , 2020, Nature Reviews Molecular Cell Biology.

[57]  Prabhanjan S. Giram,et al.  LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer. , 2020, Materials science & engineering. C, Materials for biological applications.

[58]  Mateusz Kciuk,et al.  Mechanisms of Multidrug Resistance in Cancer Chemotherapy , 2020, International journal of molecular sciences.

[59]  J. Cheong,et al.  PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells , 2020, Journal of experimental & clinical cancer research : CR.

[60]  Shi‐Mei Zhuang,et al.  LncRNA GOLGA2P10 is induced by PERK/ATF4/CHOP signaling and protects tumor cells from ER stress-induced apoptosis by regulating Bcl-2 family members , 2020, Cell Death & Disease.

[61]  Junia C Costa,et al.  Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition , 2020, International journal of molecular sciences.

[62]  Jinliang Hu,et al.  Activating transcription factor 6 regulated cell growth, migration and inhibiteds cell apoptosis and autophagy via MAPK pathway in cervical cancer. , 2020, Journal of reproductive immunology.

[63]  S. Oakes,et al.  Endoplasmic Reticulum Stress Signaling in Cancer Cells. , 2020, The American journal of pathology.

[64]  Ian H. Guldner,et al.  Cell surface GRP78 promotes stemness in normal and neoplastic cells , 2020, Scientific Reports.

[65]  Q. Gao,et al.  IRE1α-targeting Downregulates ABC Transporters and Overcomes Drug Resistance of Colon Cancer Cells. , 2020, Cancer letters.

[66]  Hui Liu,et al.  miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78 , 2020, Frontiers in Oncology.

[67]  Gong Yang,et al.  ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy , 2020, Cell Death & Disease.

[68]  B. van de Water,et al.  ATF6 Is a Critical Determinant of CHOP Dynamics during the Unfolded Protein Response , 2020, iScience.

[69]  A. Sartori,et al.  Harnessing DNA Double-Strand Break Repair for Cancer Treatment , 2019, Front. Oncol..

[70]  Y. Assaraf,et al.  Towards the overcoming of anticancer drug resistance mediated by p53 mutations. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[71]  Chenlian Yang,et al.  Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer. , 2019, Histology and histopathology.

[72]  Neil Vasan,et al.  A view on drug resistance in cancer , 2019, Nature.

[73]  S. Kim,et al.  Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51 , 2019, Breast Cancer Research.

[74]  Yuliang Li,et al.  Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway , 2019, Cell Death & Disease.

[75]  Y. Assaraf,et al.  The multi-factorial nature of clinical multidrug resistance in cancer. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[76]  S. Leng,et al.  Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non–small‐cell lung cancer cells , 2019, Molecular carcinogenesis.

[77]  Linfu Li,et al.  Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells , 2019, Journal of Cancer.

[78]  L. Galluzzi,et al.  Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. , 2019, Trends in cell biology.

[79]  Eduard Batlle,et al.  Transforming Growth Factor-β Signaling in Immunity and Cancer. , 2019, Immunity.

[80]  G. Stassi,et al.  Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance , 2019, Molecular Cancer.

[81]  T. Bivona,et al.  Polytherapy and Targeted Cancer Drug Resistance. , 2019, Trends in cancer.

[82]  B. Durden,et al.  ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness” , 2019, Cell Death & Disease.

[83]  Piyush B. Gupta,et al.  Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance. , 2019, Cell stem cell.

[84]  Yunbao Pan,et al.  Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51. , 2019, Cellular signalling.

[85]  Á. Somoza,et al.  Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment , 2018, Cellular and Molecular Life Sciences.

[86]  W. Dong,et al.  Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[87]  Tao Zhang,et al.  Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer. , 2018, Cancer letters.

[88]  R. Amaravadi,et al.  Targeting autophagy in cancer , 2018, Cancer.

[89]  H. Yao,et al.  Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 , 2018, Nature Communications.

[90]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[91]  R. Uzzo,et al.  The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma , 2018, Cell Death & Disease.

[92]  Ita Novita Sari,et al.  Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment , 2018, Stem cells international.

[93]  A. Shaw,et al.  Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.

[94]  V. Sasidharan Nair,et al.  Immune checkpoint inhibitors in cancer therapy: a focus on T‐regulatory cells , 2018, Immunology and cell biology.

[95]  J. Graf,et al.  Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures , 2017, PloS one.

[96]  H. Clevers,et al.  Cancer stem cells revisited , 2017, Nature Medicine.

[97]  Ryohei Katayama,et al.  Therapeutic strategies and mechanisms of drug resistance in anaplastic lymphoma kinase (ALK)-rearranged lung cancer. , 2017, Pharmacology & therapeutics.

[98]  Chiara Riganti,et al.  PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy , 2017, Molecular Cancer.

[99]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[100]  Ting Wu,et al.  Tumor microenvironment and therapeutic response. , 2017, Cancer letters.

[101]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[102]  Juan R. Cubillos-Ruiz,et al.  Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer , 2017, Cell.

[103]  T. Fahey,et al.  Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib , 2017, The Journal of clinical endocrinology and metabolism.

[104]  Alberto Mantovani,et al.  Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.

[105]  D. Lambrechts,et al.  Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response , 2016, Translational oncology.

[106]  J. Joyce,et al.  STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation. , 2016, Cell reports.

[107]  J. Shim,et al.  Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer , 2016, Molecules.

[108]  C. Blanpain,et al.  Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.

[109]  J. Chen,et al.  Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp. , 2016, Oncology reports.

[110]  Peter Walter,et al.  Translation from the 5′ untranslated region shapes the integrated stress response , 2016, Science.

[111]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[112]  E. Taylor,et al.  Imiquimod‐induced apoptosis of melanoma cells is mediated by ER stress‐dependent Noxa induction and enhanced by NF‐κB inhibition , 2015, Journal of cellular and molecular medicine.

[113]  Juan R. Cubillos-Ruiz,et al.  ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis , 2015, Cell.

[114]  T. Zhou,et al.  RACK1 modulates apoptosis induced by sorafenib in HCC cells by interfering with the IRE1/XBP1 axis. , 2015, Oncology reports.

[115]  G. Peters,et al.  Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia , 2015, Journal of Hematology & Oncology.

[116]  Gong Yang,et al.  Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. , 2015, Cancer letters.

[117]  Philip Levy Ho,et al.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.

[118]  J. Gustafsson,et al.  ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway , 2014, Oncogene.

[119]  A. Puisieux,et al.  Oncogenic roles of EMT-inducing transcription factors , 2014, Nature Cell Biology.

[120]  Jai-Sing Yang,et al.  The roles of endoplasmic reticulum stress and mitochondrial apoptotic signaling pathway in quercetin‐mediated cell death of human prostate cancer PC‐3 cells , 2014, Environmental toxicology.

[121]  Eduard Batlle,et al.  Metastatic stem cells: sources, niches, and vital pathways. , 2014, Cell stem cell.

[122]  M. Herlyn,et al.  Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. , 2014, The Journal of clinical investigation.

[123]  H. Tseng,et al.  Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress. , 2014, Cellular signalling.

[124]  D. Klionsky,et al.  An overview of autophagy: morphology, mechanism, and regulation. , 2014, Antioxidants & redox signaling.

[125]  M. Hsiao,et al.  Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78 , 2013, Oncogene.

[126]  J. Su,et al.  Sinulariolide Induced Hepatocellular Carcinoma Apoptosis through Activation of Mitochondrial-Related Apoptotic and PERK/eIF2α/ATF4/CHOP Pathway , 2013, Molecules.

[127]  D. Steindler,et al.  The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance , 2013, EMBO molecular medicine.

[128]  Tae Min Kim,et al.  Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[129]  Amy S. Lee,et al.  The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies , 2013, Oncogene.

[130]  U. Jaehde,et al.  Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells. , 2012, Journal of inorganic biochemistry.

[131]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.

[132]  E. Hahn,et al.  Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. , 2012, International journal of oncology.

[133]  Jun-ling Liu,et al.  Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells , 2012, Journal of cellular biochemistry.

[134]  K. Choi Autophagy and cancer , 2012, Experimental & Molecular Medicine.

[135]  S. Qiu,et al.  Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis , 2011, Autophagy.

[136]  K. Nan,et al.  Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. , 2011, International journal of oncology.

[137]  Shengbing Huang,et al.  The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.

[138]  D. Ron,et al.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress , 2011, Nature Cell Biology.

[139]  Sandra Barth,et al.  Autophagy: cellular and molecular mechanisms , 2010, The Journal of pathology.

[140]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[141]  P. Wei,et al.  Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma , 2010, Annals of Surgical Oncology.

[142]  Ying Tang,et al.  Repression of the miR‐17‐92 cluster by p53 has an important function in hypoxia‐induced apoptosis , 2009, The EMBO journal.

[143]  P. Fagone,et al.  ATF6α induces XBP1-independent expansion of the endoplasmic reticulum , 2009, Journal of Cell Science.

[144]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[145]  P. Hersey,et al.  Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. , 2009, Carcinogenesis.

[146]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[147]  Chao Zhang,et al.  IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response , 2007, Science.

[148]  Amy S. Lee,et al.  GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. , 2007, Cancer research.

[149]  Zhaohui Xu,et al.  The crystal structure of human IRE1 luminal domain reveals a conserved dimerization interface required for activation of the unfolded protein response , 2006, Proceedings of the National Academy of Sciences.

[150]  Amy S. Lee,et al.  GRP78/BiP Is Required for Cell Proliferation and Protecting the Inner Cell Mass from Apoptosis during Early Mouse Embryonic Development , 2006, Molecular and Cellular Biology.

[151]  Peter Walter,et al.  On the mechanism of sensing unfolded protein in the endoplasmic reticulum. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[152]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[153]  S. Gambhir,et al.  Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. , 2004, Human gene therapy.

[154]  R. Eils,et al.  From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[155]  Randal J. Kaufman,et al.  Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors , 2003, Journal of Biological Chemistry.

[156]  R. Kaufman Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.

[157]  Xi Chen,et al.  ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. , 2002, Developmental cell.

[158]  H. McLeod,et al.  Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. , 2001, Biochemical pharmacology.

[159]  P. N. Rao,et al.  Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.

[160]  X. Chen,et al.  ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. , 2000, Molecular cell.

[161]  Jeffrey M. Skerker,et al.  Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. , 1992, Cancer research.

[162]  D. Macer,et al.  Endoplasmic reticulum contains a common, abundant calcium-binding glycoprotein, endoplasmin. , 1986, Journal of cell science.

[163]  Xiao-dong Liu Transporter-Mediated Drug-Drug Interactions and Their Significance. , 2019, Advances in experimental medicine and biology.

[164]  P. Fisher,et al.  Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer. , 2018, Advances in cancer research.

[165]  A. Chaudhary,et al.  Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[166]  J. Shih,et al.  ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. , 2013, Cancer letters.

[167]  V. Adam,et al.  Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances. , 2012, Pharmacology & therapeutics.